NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

A Fresh Look at Arcutis Biotherapeutics (ARQT) Valuation Following Recent Shareholder Returns

Arcutis Biotherapeutics (ARQT) has seen its stock gain traction recently, delivering a strong rally over the past month along with particularly impressive growth in the past 3 months. Investors have steady reasons to watch these trends closely. See our latest analysis for Arcutis Biotherapeutics. Arcutis Biotherapeutics has been on a remarkable run lately, with the share price rallying sharply over the last three months and momentum building as the year progresses. Over the past year, the...
NYSE:IQV
NYSE:IQVLife Sciences

How Investors Are Reacting To IQVIA Holdings (IQV) Q3 Earnings and Nobel Laureate Board Appointment

IQVIA Holdings announced third-quarter 2025 results, reporting revenue of US$4.10 billion and net income of US$331 million, alongside reaffirmed full-year guidance and the appointment of Nobel laureate Dr. William G. Kaelin Jr. to its board of directors. The addition of Dr. Kaelin, an influential physician-scientist recognized for his achievements in cancer research and ongoing board leadership at Eli Lilly, reflects IQVIA's focus on scientific leadership and industry expertise at the board...
NYSE:AX
NYSE:AXBanks

Is Axos Financial's (AX) Focus on Efficiency Hiding Deeper Shifts in Its Business Model?

Axos Financial announced its quarterly earnings for the first quarter ended September 30, 2025, reporting net interest income of US$291.05 million and net income of US$112.35 million, both nearly unchanged from the prior year, with diluted earnings per share at US$1.94. An interesting aspect is Axos Financial's ongoing commitment to operational efficiency and technology use, highlighted by its stable margins and disciplined expense management, even as it completed its previously announced...
NYSE:SARO
NYSE:SAROAerospace & Defense

Strong Q3 Results and Major USAF Engine Delivery Might Change The Case For Investing In StandardAero (SARO)

StandardAero reported strong third-quarter 2025 results, with sales rising to US$1.50 billion and net income increasing significantly compared to the prior year, alongside the company’s delivery of its 1,000th GE Aerospace J85-5 engine to the United States Air Force. This operational milestone highlights StandardAero’s expanding role in critical military engine maintenance and reinforces the company’s ties with key government contracts. With significant year-over-year earnings growth and a...